UV1 vaccine combination shows no significant PFS improvement in BRCA wild type recurrent ovarian cancer

Political prioritisation as a driver of vaccine introduction: Evidence from Nigeria’s HPV rollout

Equitable HPV vaccination for all

Biomarker guided PARP inhibitor maintenance improves outcomes in ovarian cancer meta analysis of phase 3 trials

Immune checkpoint inhibitors show setting specific benefit in ovarian cancer meta analysis of 17 randomised trials

Relacorilant chemo combination extends OS in platinum-resistant ovarian cancer

Short-term fasting linked to improved chemo response in advanced ovarian cancer

Aspirin use linked to improved survival in endometrial cancer

Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment

Zedoresertib plus lunresertib shows promising tumour shrinkage in CCNE1-amplified and FBXW7-mutant cancers

Reducing cancer burden through prevention

Raising awareness and increasing HPV vaccination coverage in Kazakhstan